seqDesign

Simulation and Group Sequential Monitoring of Randomized Two-Stage Treatment Efficacy Trials with Time-to-Event Endpoints

CRAN Package

A modification of the preventive vaccine efficacy trial design of Gilbert, Grove et al. (2011, Statistical Communications in Infectious Diseases) is implemented, with application generally to individual-randomized clinical trials with multiple active treatment groups and a shared control group, and a study endpoint that is a time-to-event endpoint subject to right-censoring. The design accounts for the issues that the efficacy of the treatment/vaccine groups may take time to accrue while the multiple treatment administrations/vaccinations are given; there is interest in assessing the durability of treatment efficacy over time; and group sequential monitoring of each treatment group for potential harm, non-efficacy/efficacy futility, and high efficacy is warranted. The design divides the trial into two stages of time periods, where each treatment is first evaluated for efficacy in the first stage of follow-up, and, if and only if it shows significant treatment efficacy in stage one, it is evaluated for longer-term durability of efficacy in stage two. The package produces plots and tables describing operating characteristics of a specified design including an unconditional power for intention-to-treat and per-protocol/as-treated analyses; trial duration; probabilities of the different possible trial monitoring outcomes (e.g., stopping early for non-efficacy); unconditional power for comparing treatment efficacies; and distributions of numbers of endpoint events occurring after the treatments/vaccinations are given, useful as input parameters for the design of studies of the association of biomarkers with a clinical outcome (surrogate endpoint problem). The code can be used for a single active treatment versus control design and for a single-stage design.

  • Version1.2
  • R versionunknown
  • LicenseGPL-2
  • Needs compilation?No
  • Last release05/22/2019

Documentation


Team


Insights

Last 30 days

This package has been downloaded 209 times in the last 30 days. Now we're getting somewhere! Enough downloads to populate a lively group chat. The following heatmap shows the distribution of downloads per day. Yesterday, it was downloaded 22 times.

Sun
Mon
Tue
Wed
Thu
Fri
Sat
0 downloadsMar 9, 2025
0 downloadsMar 10, 2025
0 downloadsMar 11, 2025
0 downloadsMar 12, 2025
0 downloadsMar 13, 2025
4 downloadsMar 14, 2025
15 downloadsMar 15, 2025
4 downloadsMar 16, 2025
1 downloadsMar 17, 2025
11 downloadsMar 18, 2025
11 downloadsMar 19, 2025
12 downloadsMar 20, 2025
14 downloadsMar 21, 2025
6 downloadsMar 22, 2025
2 downloadsMar 23, 2025
4 downloadsMar 24, 2025
5 downloadsMar 25, 2025
5 downloadsMar 26, 2025
5 downloadsMar 27, 2025
11 downloadsMar 28, 2025
4 downloadsMar 29, 2025
2 downloadsMar 30, 2025
5 downloadsMar 31, 2025
5 downloadsApr 1, 2025
5 downloadsApr 2, 2025
4 downloadsApr 3, 2025
4 downloadsApr 4, 2025
6 downloadsApr 5, 2025
13 downloadsApr 6, 2025
5 downloadsApr 7, 2025
3 downloadsApr 8, 2025
5 downloadsApr 9, 2025
4 downloadsApr 10, 2025
12 downloadsApr 11, 2025
22 downloadsApr 12, 2025
1
22

The following line graph shows the downloads per day. You can hover over the graph to see the exact number of downloads per day.

Last 365 days

This package has been downloaded 2,751 times in the last 365 days. Now we’re talking! This work is officially 'heard of in academic circles', just like those wild research papers on synthetic bananas. The day with the most downloads was Jul 21, 2024 with 137 downloads.

The following line graph shows the downloads per day. You can hover over the graph to see the exact number of downloads per day.

Data provided by CRAN


Binaries


Dependencies

  • Depends1 package
  • Suggests2 packages